Invitrogen™ Mouse Endostatin ELISA Kit

Ref.: BL-RE-092539Manufacturer ref.: EM25RBX10 10 x 96 tests
€4,995.00 excl. VAT

Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.

Accession number
agent antiangiogénique ; COL18A1 ; chaîne collagène alpha-1(XVIII) ; chaîne collagène alpha1 de type XVIII ; collagène, type XVIII, alpha 1 ; endostatine ; FLJ27325 ; FLJ34914 ; KNO ; KNO1 ; KS ; MGC74745 ; protéine multifonction MFP ; NC1 ; domaine non collagéneux 1 ; procollagène, type XVIII, alpha 1
Dose range
2.458 to 600 ng/ml
Sensitivity of the dosage
2.5 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.

Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.

L-endostatin may cause an ununiform response to the proliferation, cell assembly and migration of endothelial cells, which have a different bonding characteristic to l-endostatin, leading to the hypothesis that the d-endostatin effect depends heavily on the endothelial cell type. In addition, l的endostatin inhibits in vivo l的angiogenesis and tumour growth by inducing apoptosis in endothelial cells. Local administration of d-endostatin appears to affect specifically microvessels associated with tumours by reducing the density, diameter and functionality of the vessel. The migration and invasion of tumour cells were significantly reduced in l-endostatin-treated animals. L的endostatin is non-toxic and does not induce any acquired resistance to drugs and has therefore become a new powerful therapy strategy in solid neoplastics. This treatment appears to have a high potential not only for the treatment of glioma, the most common brain tumours, but also for other tumours. The ability of løendostatin to inhibit neoangiogenesis is mediated, at least in part, by Zn^+2 binding and l −elastase treatment. Generalised expression of l的endostatin was detected in elactic fibers in vessel walls and in some other basal membrane areas. L的endostatin is released by neurons to accumulate in amyloid plaques in Alzheimer's disease.

Sensitivity

Sensitivity of the dosage: 2.5 ng/ml.

Measurement range

Dose range: 2.458 to 600 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: Endostatin.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17824230
Specifications
Accession numberantiangiogenic agent; COL18A1; collagen chain alpha-1(XVIII); collagen chain alpha1 type XVIII; collagen, type XVIII, alpha 1; endostatin; FLJ27325; FLJ34914; KNO; KNO1; KS; MGC74745; multifunctional protein MFP; NC1; non-collagen domain 1; procollagen type XVIII, alph
Dose range2.458 to 600 ng/ml
Sensitivity of the dosage2.5 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P39061
Gene symbol(s)COL18A1
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusUse exclusively for research
TargetEndostatin
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl; Plasma, 50 μl; Supernatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EM25RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.